Ipamorelin
Selective GHRP studied for growth hormone secretion.
Ipamorelin is Selective GHRP studied for growth hormone secretion. Whether it is appropriate depends on your medical history, goals, current medications, and testing — evaluated by a licensed VidaVital Medical provider during a live consultation. Educational content only; not medical advice.
- Ipamorelin is available as a compounded prescription (not FDA-approved).
- Recent labs are recommended before evaluation.
- Providers may evaluate it in hormone-health, recovery.
- A licensed VidaVital provider must complete a live consultation before any treatment is prescribed.
What is it?
Selective GHRP studied for growth hormone secretion. A licensed provider reviews suitability, monitoring, and any needed testing during a live consultation.
What may it support?
- Recovery
- Sleep support
Where might it fit?
Bloodwork & monitoring
Potential side effects
- Injection-site reaction
- Mild GI discomfort
- Rare allergic reaction
Who may not be a candidate?
- • Pregnancy
- • Active malignancy without oncology clearance
Drug interactions
- • Providers review all medications during consultation
Regulatory disclosures
Speak With a Licensed Medical Provider
If you're interested in learning whether peptide therapy may be appropriate for your health goals, schedule a consultation with a licensed VidaVital Medical provider. Your provider will review your medical history, discuss available treatment options, and determine whether any therapy is appropriate for your individual needs.
Frequently asked questions
Sources
- Provider-reviewed clinical summary — reviewed 2026-01-15 by VidaVital Medical